Benzinga | Dec 7, 2021 04:59AM EST

Cowen & Co. Initiates Coverage On Moderna with Market Perform Rating, Announces Price Target of $250

Cowen & Co. analyst Tyler Van Buren initiates coverage on Moderna (NASDAQ:MRNA) with a Market Perform rating and announces Price Target of $250.